A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

This study has been completed.

Study NCT00641589. Last updated on March 17, 2008. Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00641589

Sponsors and Collaborators

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Centocor Ortho Biotech Services, L.L.C.

Investigators


Study Director:	Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trial	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.